Cyclo Therapeutics Completes Phase 3 Trial Enrollment, Plans 2025 NDA Filing Amid Merger CYTH Stock News - StockTitan
| AMPGW Stock | USD 0.02 0.01 33.33% |
Slightly above 61% of AmpliTech's investor base is looking to short. The analysis of overall sentiment of trading AmpliTech Group stock suggests that many investors are alarmed at this time. AmpliTech's investing sentiment can be driven by a variety of factors including economic data, AmpliTech's earnings reports, geopolitical events, and overall market trends.
AmpliTech |
Cyclo Therapeutics Completes Phase 3 Trial Enrollment, Plans 2025 NDA Filing Amid Merger CYTH Stock News StockTitan
Read at news.google.com
 |
AmpliTech Fundamental Analysis
We analyze AmpliTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AmpliTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AmpliTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
AmpliTech is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
AmpliTech Group Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AmpliTech stock to make a market-neutral strategy. Peer analysis of AmpliTech could also be used in its relative valuation, which is a method of valuing AmpliTech by comparing valuation metrics with similar companies.
Peers
AmpliTech Related Equities
| CYTHW | Cyclo Therapeutics | 0.00 |
| ||
| AMPG | Amplitech | 1.11 |
|
Additional Tools for AmpliTech Stock Analysis
When running AmpliTech's price analysis, check to measure AmpliTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AmpliTech is operating at the current time. Most of AmpliTech's value examination focuses on studying past and present price action to predict the probability of AmpliTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AmpliTech's price. Additionally, you may evaluate how the addition of AmpliTech to your portfolios can decrease your overall portfolio volatility.